Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at ...

The founding director of the FDA’s Office of Biotechnology writes that new evidence suggests COVID may be a novel, additional ...

Dr Rebecca Dobson discussed the acute need to assess cardiovascular risk in cancer care, cardiotoxicity and the MDT in cardio-oncology.